A Day Up For NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) jumped higher at $3.94, representing a gain of 26.7%. On Fri, Jun 11, 2021, NRBO:NASDAQ touched a New 2-Week Intraday High of $3.23. The stock got featured on our News Catalysts scanner on Mon, May 17, 2021 at 06:26 PM in the 'EARNINGS' category. From Fri, May 28, 2021, the stock recorded 77.78% Up Days and 70.00% Green Days

The stock spiked on Wed, Jan 06, 2021 at $7.61 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.